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Mucormycosis fungemia is rarely documented since blood cultures are nearly always negative. We describe a case of Mucor
circinelloides fungemia in a patient with a history of a sinus infection, sarcoidosis, and IgG deficiency.The identity of the isolate was
supported by itsmicroscopicmorphology and its ability to convert into yeast forms under anaerobic conditions.The early detection,
initiation of liposomal amphotericin B treatment, and reversal of underlying predisposing risk factors resulted in a good outcome.
1. Introduction
Mucormycoses are infectious diseases caused by filamen-
tous fungi classified among the order Mucorales [1]. Infec-
tion occurs when a susceptible (e.g., immunocompromised)
human is exposed to spores through inhalation, ingestion, or
traumatic implantation. The resulting disease processes are
characterized by an often rapid clinical progression and a
high mortality rate [1, 2]. Mucorales rarely cause infection in
immunocompetent persons but can cause fatal infection in
immunocompromised patients. Risk factors include hema-
tologic malignancies, bone marrow or solid organ trans-
plantation, neutropenia, diabetes mellitus, corticosteroids,
iron chelation therapy, broad spectrum antibiotics, anti-
fungal prophylaxis, prolonged voriconazole use, cutaneous
breakdown (from trauma, surgical wounds, needle-sticks, or
burns), hyperalimentation, and severe malnutrition [1, 2].
Features of these organisms that contribute to their virulence
include their rapid growth rate and their ability to invade
blood vessels [1–3]. The latter characteristic permits their
spread throughout the body, enabling access to numerous
tissues and organs that may ultimately become infected [2].
However, documented mucormycosis fungemia is very rare,
and blood cultures are usually negative. Demonstration of
invasive disease by these organisms generally requires the
identification of fungal elements directly in clinical speci-
mens via histopathological examination or growth of these
organisms from more than one specimen obtained from a
normally sterile site [3].
Several Mucor spp., but not all, are known to be dimor-
phic. This distinct group of zygomycetes exhibits hyphal
growth in aerobic conditions and multibudded yeast growth
under anaerobic or high-CO
2
conditions [4].M. circinelloides
is one of these species, along with M. racemosus, M. rouxii,
M. genevensis, M. bacilliformis, M. subtilissimus, and M.
amphibiorum. M. circinelloides infections are well docu-
mented in the literature and have been associated with cuta-
neous, rhinocerebral, and pulmonary infections [5–9]. To our
knowledge, only two cases of fungemia caused by this organ-
ism have been reported [10, 11]. In this report we describe a
case ofM. circinelloides fungemia in a female with a prior his-
tory of chronic sinus infection, sarcoidosis, and IgG defi-
ciency.
2. Case Report
A 38-year-old female presented to the Emergency Depart-
ment of a hospital in rural Indiana with shortness of breath
and cough, sinus congestion, fevers as high as 39.4∘C, nasal
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Figure 1: Gram stain of M. circinelloides dimorphic phases from a positive blood culture. (a) Pauciseptate wide hyphae with right-angle
branching (100x magnification). (b) Circumferentially budding yeast resembling the yeast phase of Paracoccidioides brasiliensis (500x
magnification).
Table 1: Clinical laboratory test results from blood specimens
obtained at the time of patient presentation to the ED.
Test Patient result Reference range
WBC 13.7k/cumm 3.6–5.17k/cumm
Hgb 11.5 GM/dL 12.0–16.0GM/dL
MCV 79 fL 81–99 fL
MCH 24.9 pg 27–34 pg
MCHC 31.5 GM/dL 32.0–36.0GM/dL
RDW 15.8% 11.5–14.5%
Absolute neutrophil 8.2k/cumm 1.7–7.6k/cumm
Absolute lymphocyte 4.0k/cumm 1.0–3.2k/cumm
Absolute eosinophil 0.4k/cumm 0.0–0.3k/cumm
Potassium SerPl QN 2.8mmol/L 3.5–5.5mmol/L
Carbon dioxide SerPl QN 21mmol/L 22–29mmol/L
Glucose SerPl QN 138mg/dL 70–99mg/dL
Magnesium SerPl QN 1.3mg/dL 1.6–2.9mg/dL
AST SerPl QN 8 units/L 13–39 units/L
Total protein SerPl QN 6.0GM/dL 6.4–8.0GM/dL
drainage, sore throat, and yellow-green sputum produc-
tion. The patient’s medical history included sarcoidosis, IgG
deficiency, and a sinus infection for which she completed
treatment with cefdinir 1 week before admission. The patient
stated improvement while on antibiotics but symptoms
worsened after therapy completion. Upon physical examina-
tion, the patient had a temperature of 37.5∘C and exhibited
moderate respiratory distress with no wheezing, rales, or
rhonchi. She was alert, awake, and oriented with no ear,
nose, throat, cardiovascular, abdominal, back, extremities,
skin, neurological, or psychiatric abnormalities. An X-ray
of her chest was unremarkable. Peripheral blood specimens
obtained at the time of initial presentation demonstrated
leukocytosis, hyperglycemia and low potassium, CO
2
, total
protein, and magnesium (Table 1). The aerobic blood culture
bottles (BD BACTEC Plus Aerobic/F) from two sets of
blood cultures collected at the time of admission turned
positive within 24 hours of incubation in a continuous-
monitory blood culture system (BACTEC 9240, BD Diag-
nostics, Sparks, MD). Gram stains of the broth revealed
pleomorphic yeast forms andwide, pauciseptate, hyphaewith
right-angle branching (Figure 1(a)). Yeast forms with single,
bipolar, and circumferential buds were observed. Several
of the yeast cells observed resembled the yeast phase of
Paracoccidioides brasiliensis (Figure 1(b)). The Gram stain
findings were reported as “fungal elements present” and were
immediately phoned to the clinical care team.
The following day, mold growth was observed on the
aerobic sheep blood agar and chocolate agar plates incu-
bated at 35∘C in 5% CO
2
and on potato dextrose and
Sabouraud agars incubated at 30∘C. Fast-growing, floccose
colonies were initially pale gray to yellow, turning brown
over time when incubated at 35∘C. Microscopic examination
of the mold colony by lactophenol cotton blue staining
revealed broad, ribbon-like pauciseptate wide hyphae with
right-angle branching. Sympodially branched and circinate
sporangiophores were observed (Figures 2(a) and 2(b)).
Globose sporangiameasuredwithin 25–80𝜇mand contained
oval shaped sporangiospores (Figure 2(c)). Columellae were
spherical, measuring up to 50𝜇m in diameter; collarettes
were present (Figure 2(d)). Rhizoids and stolons were absent.
The identity of the isolate as M. circinelloides was supported
by itsmicroscopicmorphology, its ability to convert into yeast
forms under anaerobic conditions, and its inability to grow at
42∘C (Figure 3). Conclusive identification based on molec-
ular and phenotypic methods was above the scope of this
study. Following reporting of these findings, the patient was
started on liposomal amphotericin B 500mg IVPB every 24
hours; subsequent blood and sinus cultures were negative. In
addition, sinus biopsy results and computerized tomography
(CT scan) of the chest and sinuses did not show any clear
evidence of fungal involvement. As a consequence, antifungal
treatment was discontinued after 6 days and the patient was
discharged home without further complications. The patient
had no signs ofMucor infection 7 months after discharge.









Figure 2: Microscopic examination of Mucor circinelloides on PDA by “tape prep” using lactophenol cotton blue stain. (a) Sympodially
branched sporangiophores (100x magnification); (b) circinate sporangiophores (200x magnification); (c) deliquescent sporangia (100x
magnification); (d) columella with collarette (200x magnification).
20 𝜇m
Figure 3: Mucor circinelloides yeast forms after cultivation of the
isolate on Sabouraud dextrose agar incubated for 48 hrs under
anaerobic conditions showing hyphae with single and multipolar
buds (unstained, 200x)
3. Discussion
The saprophytic nature of theMucorales makes the diagnosis
ofmucormycosis a challenging taskwhen these organisms are
isolated fromnonsterile sites [1]. Because they are ubiquitous,
the presence of these organisms can sometimes be dismissed,
as, in many cases, they likely represent contamination of the
clinical specimen or culture media. Therefore, it is essential
that the physician and laboratory personnel work together to
determine the clinical significance of the laboratory results.
In most instances, the diagnosis of invasive mucormycosis
is usually made when these organisms are identified directly
from clinical specimens or isolated in culture frommore than
one specimen obtained from a normally sterile site. In the
case presented, the diagnosis of mucormycosis was made by
the isolation of Mucor circinelloides from two blood culture
sets that were collected from two different sites. This finding
was considered clinically significant since it represented
multiple specimens obtained from a normally sterile site.
In this case, the source of infection is unknown, but
we hypothesized that is likely related to her sinusitis. The
successful treatment and optimal outcome were most likely
attributed to the early detection and isolation of the organism
from blood cultures, which prompted early implementation
of antifungal therapy. In addition, the correction of her
hypokalemia, hypomagnesemia, and hyperglycemia con-
tributed to her recovery, as reversal of underlying physiologi-
cal dyshomeostatic conditions has been reported to correlate
with good patient outcomes [12]. Surgical debridement was
not necessary since follow-up tests did not reveal foci of
fungal infection. Based on the patient outcome, we can also
hypothesize that this case might have represented a transient
fungemia or that the causative organism is of low virulence
[13].
To our knowledge, only two cases of fungemia associated
with M. circinelloides have been previously described. The
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first reported cases occurred in a 48-year-old male with
a history of short-gut syndrome secondary to multiple
abdominal surgeries [10]. This patient had a central venous
catheter (CVC) that was required for chronic total parenteral
nutrition. Blood cultures obtained from the CVC on consec-
utive days grew both Candida albicans and M. circinelloides.
Treatment with liposomal amphotericin B was started, and
the CVC was removed. Similar to our case, the authors stated
that early diagnosis of mucormycosis coupled with rapid
therapeutic intervention led to a successful outcome. The
second reported case was that of an 83-year-old diabetic
woman who developed an acute left frontoparietal infarct
while hospitalized in a neurological intensive care unit [11].
The initial isolation of a mold from a blood culture was con-
sidered to be a contaminant, but during the following days,
the patient developed an erythematous and edematous lesion
on her right hand. A skin biopsy culture grew amold identical
to that in the blood culture; both isolates were later identified
asM. circinelloides bymolecular methods. Despite treatment,
the patient’s clinical condition worsened and she later died.
4. Conclusion
This case represents the third documented case of fungemia
cause byM. circinelloides. The most likely underlying factors
were probably related to her chronic sinus infection, IgG
deficiency, and chronic steroid use.Thedetection of thismold
and reversal of the predisposing underlying conditions were
vital in the successful treatment.
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